Loading...
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data
PURPOSE: To evaluate the impact of including a medicine in the list of medicinal products subject to additional monitoring (AM) on the reporting of adverse drug reactions (ADRs) in the european economic area (EEA). METHODS: Interrupted time series using the monthly number of EEA ADR reports in Eudra...
Na minha lista:
| Udgivet i: | Pharmacoepidemiol Drug Saf |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7898803/ https://ncbi.nlm.nih.gov/pubmed/33197106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.5174 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|